0001213900-22-073942.txt : 20221118 0001213900-22-073942.hdr.sgml : 20221118 20221118193345 ACCESSION NUMBER: 0001213900-22-073942 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221114 FILED AS OF DATE: 20221118 DATE AS OF CHANGE: 20221118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOUDENBERG MICHAEL CENTRAL INDEX KEY: 0001817884 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 221403210 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4/A 1 ownership.xml X0306 4/A 2022-11-14 2022-11-15 0 0001728328 InMed Pharmaceuticals Inc. INM 0001817884 WOUDENBERG MICHAEL C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Operating Officer Employee Stock Option (Right to Buy) 2.78 2022-11-14 4 D 0 7500 0.00 D 2027-11-13 Common shares 7500 3842 D The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant. On September 7, 2022, the Issuer's common stock was reverse split on a 1-for-25 basis. This number reflects that reverse stock split. On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 7,500 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,842 derivative securities of the Issuer. /s/ Eric A. Adams, attorney-in-fact for Mr. Michael Woudenberg 2022-11-18